Baxter reports increase in fourth-quarter sales, full-year revenue for 2021
Click Here to Manage Email Alerts
Baxter International Inc. reported net sales of $3.5 billion for the fourth quarter of 2021 and a full-year revenue of $12.8 billion.
According to a press release, the fourth-quarter sales and full-year revenue increased “10% on a reported basis.” The fourth-quarter net sales showed a 12% increase on a constant currency basis and an U.S. generally accepted accounting principles (GAAP) earnings per share of $0.47. Similarly, the overall U.S. GAAP earnings per share for Baxter in 2021 was $2.53.
“Amid a historic pandemic and global supply chain challenges, Baxter achieved solid top- and bottom-line growth for the fourth quarter and full year. Performance reflects sustained demand for our portfolio of medically essential products coupled with the impact of our ongoing transformation,” José E. Almeida, chair, president and CEO of Baxter, said in the release. “Our December 2021 acquisition of Hillrom creates new potential for our team to advance connected care solutions, expand portfolio access and capture efficiencies to drive enhanced value for patients, clinicians, employees, investors and other stakeholders.”
Read more about
Click Here to Manage Email Alerts